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ess: marrone@ibim.cnr.Summary The aim of the study was to assess how the analysis of different signals
recorded during application of automatic continuous positive airway pressure
(autoCPAP) devices improves the evaluation of pressure titration in patients with
obstructive sleep apnea syndrome (OSAS) naive to treatment. Seventy-two patients
underwent nocturnal polysomnography during autoCPAP (Autoset T, ResMed, Sydney,
Australia) application. Progressively more complex combinations of signals were
analysed in consecutive steps. According to the analysis of oxyhemoglobin saturation
(SaO2) alone, a fixed CPAP level suitable for treatment could not be identified in 3
subjects. When analysis of posture was added, titration was considered unsatisfac-
tory in 1 more subject, due to a short time spent supine. Further, addition of flow
and respiratory movements led to consider titration unsatisfactory in 1 more
subject. Analysis of all polysomnographic signals demonstrated a not fully reliable
titration in 9 subjects: 1 with short sleep duration, 2 without REM sleep, 4 with a
short sleep time spent supine, and 3 subjects (already identified by SaO2) with
insufficient correction of respiratory disorders even when a relatively high CPAP was
administered. Mask leaks did not hamper titration. CPAP titration by automatic
devices alone results in imperfect titration in410% subjects naive to ventilatory
treatment. Only polysomnographic recording ensures titration reliability in all
patients. Further research is needed to identify simple and economic methods to
reliably start the CPAP treatment.
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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it (O. Marrone).Introduction
It is still recommended to titrate continuous
positive airway pressure (CPAP) before prescribing
it as a long-term treatment for obstructive sleeped.
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O. Marrone et al.314apnea syndrome (OSAS). According to official
statements, CPAP titration must be performed
during polysomnography, while a technician adjusts
the pressure delivered so as to identify pressure
levels preventing upper airway obstruction during
sleep.1 However, the most appropriate criteria for
identification of such levels are still uncertain, as it
is not clear which respiratory and electroencepha-
lographic parameters correlate best with clinical
improvement.2 Besides, optimal pressure, what-
ever the criterion to define it, may change over
time,3 although this is not a rule.4 Therefore, some
recent studies proposed to recommend the pres-
sure level for therapy based on subjective criteria,
like adherence to treatment and improvement in
sleepiness.5,6 This approach still needs to be
validated: in fact, almost all studies comparing
titrated vs. sham CPAP showed a similar compliance
to both methods;7 besides, even sham CPAP use
may be associated to some improvement in
subjective sleepiness, despite no improvement in
objective somnolence measured by Multiple Wake-
fulness Test.8 Thus, CPAP titration during polysom-
nography before starting home treatment is not
exempt from criticism but, as long as other
methods are not proven superior, it is still the
standard procedure.
For a reliable CPAP titration, polysomnographic
studies must fulfil some criteria: monitoring should
last at least three hours in subjects whose apnea/
hypopnea index (AHI) is440, or even more in
subjects with milder disease;9,10 some REM sleep
should be recorded, since this sleep stage is
sometimes associated with higher pressure require-
ments;11–13 some sleep time should be spent in the
supine posture, as sleeping supine often requires
higher CPAP levels.12–14 This procedure is complex
and expensive; easier methods for CPAP titration
could reduce costs and waiting lists. The use of
simplified monitorings15,16 or of automatically
adjusting CPAP machines (autoCPAPs) has been
proposed for that purpose. The evidence to use
simplified monitorings for CPAP titration is still
insufficient.17
Properties of autoCPAP devices could be theore-
tically exploited to reduce the work of technicians
attending titration studies, allowing them to per-
form more titrations than usual at the same time,18
or to perform titrations by means of simplified
procedures.19 Analysis of the variable pressure
levels automatically delivered during the night by
these devices could give indications about the
optimal pressure level for home treatment by
machines delivering constant CPAP. Some studies
investigated reliability of pressure data recorded
during several nights by unattended autoCPAPmachines, without any associated monitoring,
either in patients naive to CPAP20 or adequately
trained:21 although this procedure was successful in
most patients, a variable success rate was re-
ported, due to imperfect identification of optimal
pressure20–22 or to the inability of some patients to
correctly wear nasal mask.21,23 Studies where
autoCPAP was applied for titration purposes during
single-night polysomnographic monitorings pointed
out a common need of technician interven-
tions.24,25 Nothing is known about the usefulness
of simplified nocturnal monitorings during auto-
CPAP application. Due to this paucity of data, a
committee of the American Academy of Sleep
Medicine (AASM) has recently recommended to
use validated autoCPAP devices for CPAP titration
only during attended polysomnographic studies.17
In this study, we performed attended polysomno-
graphy for CPAP titration during application of an
autoCPAP device (Autoset T) in OSAS patients naive
to ventilatory treatment, candidate to home CPAP.
Then, we evaluated the titration studies taking into
account step-by-step an increasing number of the
recorded signals. Our aim was to verify how the
information given by the analysis of different
signals recorded during autoCPAP application im-
proves the reliability of CPAP titration by automatic
devices in such patients.Patients and methods
Consecutive subjects referred for suspected OSAS,
after evaluation of clinical history, underwent a
nocturnal monitoring, consisting either of standard
polysomnography or of portable cardiorespiratory
monitoring. On these recordings, AHI was calcu-
lated as (number of apneas+hypopneas)/hour of
measured, or estimated, total sleep time (TST).
OSAS was diagnosed according to AASM recommen-
dations.26 One hundred OSAS patients with an
AHI420 were found, who were considered candi-
dates to ventilatory treatment. They tried CPAP
during daytime both to test their ability to tolerate
its application and to verify mask fitting. Eighty-
one subjects accepted ventilatory treatment, and
to undergo nocturnal polysomnography for pressure
titration. After the exclusion of 6 patients with
moderate to severe COPD, 75 subjects, 60 male and
15 female, were asked to participate to this study.
All of them gave their consent. No subject showed
significant central apneas or had congestive heart
failure. No patient had used CPAP at night before.
Characteristics of the enrolled subjects are shown
in Table 1.
ARTICLE IN PRESS
Table 1 Baseline characteristics of the subjects.
Age (yr) BMI (kg/m2) AHI (no/hour of TST) Awake SaO2 (%) Lowest SaO2 (%)
Mean7SD 54.3711.7 36.276.4 61.7720.5 95.271.6 64.9713.9
Definitions of abbreviations: BMI=body mass index; AHI=apnea/hypopnea index; SaO2=oxyhemoglobin saturation; TST=total
sleep time.
Signals for titration by auto CPAP devices 315Polysomnography was performed by a compu-
terised system (PS-2 Compumedics, Abbottsford,
Australia). CPAP titration was performed by means
of an autoCPAP machine (AutoSet T, ResMed,
Sydney, Australia) that modifies the pressure it
administers after the automatic flow detection by
in-built pneumotachograph; inspiratory airflow
limitation is the main trigger for pressure augmen-
tations. Pressure at the nasal mask was continu-
ously recorded. Patients were recommended to lie
supine for at least part of the night. A technician
was allowed to intervene only if called by patients
who asked to reapply nasal mask after having
pulled it off. The protocol was approved by the
local scientific committee.
Recordings with time in bed (TIB)43 h (if base-
line AHI was440) or44 h (in milder cases) were
analysed.9,10 Sleep was manually scored.27 Sleep
efficiency was calculated as TST/TIB 100. Arousal
index was calculated as number of arousals and
awakenings28 per hour of TST. Oxygen desaturation
index (ODI), defined as the number of oxyhemoglo-
bin saturation (SaO2) falls43%/hour of TIB, was
automatically calculated by the polysomnographic
system. Apneas and hypopneas were manually
scored. Apneas were defined as lack of airflow
(detected by thermistors) for at least 10 s, and
distinguished in central, mixed and obstructive.
Hypopneas were defined as discernible reductions
in thoraco-abdominal movements or in airflow
X10 s followed by either a SaO2 fall43% or an
arousal.26 Total number of apneas and hypopneas
per hour of TIB (AHITIB) and of TST (AHITST)
were calculated. AHI values were also calculated
excluding central apneas from the total number of
events.
Data recorded and automatically elaborated by
the machine were retrieved (ResMed Autoscan
3.12). They included: mean nocturnal CPAP level,
mean nocturnal air leak, CPAP level and air leak not
exceeded for 95% of the night (95th centile CPAP
and 95th centile leak, respectively); apneas and
hypopneas (detected by its in-built pneumotacho-
graph) per hour of TIB (AHIauto). Apneas, but not
hypopneas, are shown on the report of the device
by a symbol allowing us to identify pressure and
leak levels at their occurrence.The 95th centile CPAP was considered as the
pressure level suggested by the autoCPAP device for
the patient’s treatment by means of fixed level
CPAP machines. Reliability of titration was assessed
in four consecutive steps, taking into account
pressure levels administered by the device in
association with: (1) oxygen desaturations alone,
evaluated on the SaO2 signal; (2) oxygen desatura-
tions and time spent supine, evaluated on SaO2 and
posture signals, like in ‘‘less than full’’ respiratory
monitorings;29 (3) disordered breathing events and
time spent supine, evaluated on signals of SaO2,
posture, airflow, and respiratory movements, like
in ‘‘full’’ respiratory monitorings;29 and (4) respira-
tory and sleep characteristics, evaluated on all
polysomnographic signals. At each step, it was
evaluated if respiratory disorders were apparently
corrected in the high range of pressure levels
administered by the autoCPAP. TST o3 h, absence
of REM sleep, or time spent supine o1 h were
considered indicative of inadequate conditions for
a satisfactory CPAP titration, whatever the beha-
viour of respiratory signals. Analysis of all poly-
somnographic signals (step 4) was taken as the gold
standard for assessment of the acceptability of the
titration. Evaluations were always performed in
the same order, so that scorers were blinded to the
successive, but not to the previous evaluation.
Data are reported as mean7SD only when
normally distributed, or as median (range). Corre-
lations between variables were assessed by linear
regression analysis. Mann–Whitney test was applied
for comparisons between groups of patients. A
Po0.05 was considered significant.Results
Three subjects requested to interrupt the study
aftero3 h. All the following results are relevant to
the remaining 72 subjects.
Data calculated before EEG assessment are
shown in Table 2.
Analysis of oximetry (step 1) revealed a satisfac-
tory correction of SaO2 behaviour in most cases.
Ten subjects showed an ODI410. As in 7 of them
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Table 2 Data from polysomnography with autoCPAP before EEG assessment.
Lowest SaO2
(%)
ODI (no/hour) TIB supine
(min)
AHITIB (no/hour) Non-c. AHITIB
(no/hour)
median 89.0 3.2 339.5 4.4 3.6
range 59–95 0.0–45.7 39–496 0.0–49.5 0.0–47.7
Definitions of abbreviations: ODI=oxygen desaturation index, automatically calculated per hour of time in bed; TIB=time in bed;
AHITIB=apnea/hypopnea index, manually calculated per hour of time in bed; non-c.=non-central.
O. Marrone et al.316oxygen desaturations were mostly confined to
periods when a relatively low pressure was admi-
nistered, at this step titration was considered
unsatisfactory in 3 subjects.
Analysis of posture showed that 1 subject had
remained supine for o1 h. Combined analysis of
oximetry and posture (step 2) led to consider
titration unsatisfactory in 4 cases.
Analysis of flow and respiratory movements
revealed an AHITIB410 in 12 subjects, while, if
central apneas were excluded, it was410 in 10
subjects. As in 6 of them hypopneas and obstructive
apneas were mostly confined to periods with
relatively low pressures administration, correction
of respiratory disorders could be considered in-
sufficient in 4 subjects: three of them had already
been identified by SaO2 analysis, while the last one
had not, because most of her apneas were
associated to very mild oxygen desaturations.
Therefore, the combined analysis of all respiratory
signals and of posture (step 3) led to consider
titration unsatisfactory in 5 cases.
Polysomnography data calculated after EEG
assessment are shown in Table 3.
TST was o3 h in only 1 subject, while REM sleep
was not recorded in 2 subjects. TST supine was
o1 h in 4 subjects (one of them without REM
sleep). Altogether sleep or posture were inade-
quate for a fully reliable titration in 6 subjects. In
the remaining 66 subjects, AHITST was410 in 13
subjects, but, if central apneas were excluded, in
only 10 subjects. In 6 of the latter subjects titration
was considered satisfactory because hypopneas and
obstructive apneas were mostly confined to periods
of relatively low pressure administration; in 1
patient because obstructive events only appeared
during alternating wake and stage 1 NREM sleep in
the initial three hours of the recording, whereas
they disappeared in the final four hours, when a
stable sleep was recorded. Therefore, analysis of
all polysomnographic signals (step 4) demonstrated
that titration was imperfect or unsatisfactory in 9
subjects, and acceptable in 63 subjects.
Number of titrations that were correctly
evaluated by means of each analysis are shown in
Table 4.Data retrieved and elaborated by the autoCPAP
device are shown in Table 5. AHIauto was signifi-
cantly correlated (Po0.001) to ODI (r2 ¼ 0:28),
AHITIB, both including and not including central
apneas (r2 ¼ 0:50 and 0.38, respectively), and to
AHITST (r2 ¼ 0:56 and 0.46, with and without
central apneas, respectively). The 95th centile
leak exceeded 0.4 l/s in 18 subjects. It was
significantly, but weakly, correlated to AHIauto
(r2 ¼ 0:08; P ¼ 0:019), and to ODI (r2 ¼ 0:07;
P ¼ 0:03), but not to manually calculated AHI
values or to arousal index. Mean mask leak was
not correlated with any variable relevant to
respiratory disorders rate.
Mask was reapplied by the technician during the
night after complete removal in 7 subjects.
Among the three patients with unsatisfactory
CPAP titration due to incomplete correction of
respiratory disorders, one was an obese woman
(BMI 48.2 kg/m2) without airway obstruction at
spirometry, but who had recently recovered from
an episode of respiratory failure; her respiratory
disorders during autoCPAP application were mostly
represented by hypopneas during REM sleep;
following a new polysomnographic evaluation, she
was later recommended bilevel ventilation. The
second patient was a morbidly obese man (BMI
46.6 kg/m2) with mild airway obstruction (FEV1 88%
of predicted value, FEV1/VC 64.6%); in this patient
the autoCPAP did not prevent a moderately high
number of apneas and hypopneas, although AHI and
oxygen desaturations improved markedly with
respect to the baseline study; he refused immedi-
ate polysomnographic re-evaluation, and was re-
commended a CPAP 2 cm H2O higher than indicated
by the autoCPAP machine. The last subject, who
experienced highly desaturating obstructive apneas
throughout most of his sleep time, did not show
peculiar characteristics during autoCPAP applica-
tion; he later received polysomnographic manual
CPAP titration and was recommended a pressure
level 4 cm H2O higher than the one indicated by the
autoCPAP. The 95th centile leaks in the three
patients were, respectively, 0.44, 0.40 and 0.38 l/s.
Among the six subjects with inadequate sleep or
posture, three accepted to repeat polysomnography:
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Table 4 Titrations correctly evaluated by each
analysis.
Polysomnographic signals
analysed
Correctly evaluated
titrations
No %
None 63 87.5
SaO2 66 91.7
SaO2+posture 67 93.0
SaO2+posture+airflow+
respiratory movements
66 91.7
Signals for titration by auto CPAP devices 317the newly titrated CPAP differed from the pre-
viously obtained 95th centile CPAP by between +1
and 1 cm H2O. On average, subjective somno-
lence was less in these six subjects than in the
other 66 patients (Po0.05), but there was a large
overlap between groups (Epworth scores 6.5, range
1–23, vs. 13.3, range 1–24).Discussion
Use of unattended autoCPAP, without any simulta-
neous monitoring, has been proposed as a possible
method for identification of optimal fixed pressure
for treatment of OSAS subjects as an alternative to
manual CPAP titration during polysomnography. The
90th or the 95th centile pressure level adminis-
tered during the night by these machines is
considered indicative of the optimal pressure.24,25
In this study, in 87.5% cases, pressure levels alone
delivered by an autoCPAP machine during a single-
night in OSAS patients naive to ventilatory treat-
ment was able to provide reliable indications about
pressure level that could be administered by fixed
CPAP ventilators to prevent sleep respiratory
disorders. Respiratory and posture signals allowed
us to recognise some cases of unsatisfactory
titration, improving the effectiveness of the auto-
titration procedure; there were only minor differ-
ences among analyses based on different
combinations of such signals. Some cases of
unsatisfactory titration were due to inadequate
sleep, and could be identified only by full poly-
somnography analysis.
Correction of respiratory disorders was unsatis-
factory in 3 of the 72 patients studied here. It is
possible that pulmonary disease contributed to the
unsatisfactory autoCPAP performance in two of
these subjects, while the reason for the failure in
the third one remained obscure. It is noteworthy
that in two of these subjects the prescribed
ARTICLE IN PRESS
Table 5 Data retrieved and automatically elaborated by the Autoset T device.
Mean CPAP (cm
H2O)
95th centile CPAP
(cm H2O)
Mean air leak
(l/s)
95th centile leak
(l/s)
AHIauto
(no/hour)
Median 9.4 11.2 0.02 0.28 12.9
Range 5.8–12.6 7.6–15.4 0.0–0.48 0.0–0.96 1.3–52.5
95th centile CPAP=CPAP level not exceeded for 95% of the time in bed; 95th centile leak=air leak not exceeded for 95% of the
time in bed.
O. Marrone et al.318treatment modality differed substantially from the
one that would have been prescribed following
analysis of autoCPAP levels alone. We looked if
titration failure in these patients could be due to
excessive air leaks. For Autoset devices, it is
recommended not to exceed air leaks of 0.4 l/s,
as, beyond that point, the machines may not
correctly identify respiratory disorders and may
not work properly. The 95th centile leaks in the
three patients were within acceptable limits, or
exceeded them only very slightly. In many patients
of this study, the 95th centile air leak exceeded the
0.4 l/s threshold, but that did not result in inade-
quate correction of respiratory disorders for the
titration purposes. Therefore, titration failures
could never be attributed to lack of intervention
by a technician. In this study the intervention of
the technician was critically important only in seven
patients who had completely removed the mask.
Theoretically, information to identify cases of
imperfect correction of respiratory disorders could
be given by the autoCPAP itself. In fact, other
studies validated automatic AHI scoring by the
Autoset device.30–32 In this study, as the detection
of respiratory events by the machine and by manual
scoring on the polysomnography were based on
different signals and criteria, we could not exactly
control the accuracy of AHIauto. Nevertheless, the
values of AHIauto and AHITST were significantly
correlated, suggesting that AHIauto could probably
help to evaluate adequacy of correction of respira-
tory disorders when no monitoring is performed
during the Autoset T device application. However,
the report of the machine does not inform us about
the precise time and pressure levels administered
when hypopneas are detected. Therefore, AHIauto
appears more useful to evaluate Autoset T effec-
tiveness when it is applied for treatment. If it is
applied for pressure titration, rather than the
number and the frequency of respiratory disorders,
it is important to know how respiratory disorders
are corrected at each administered pressure level.
For that reason, usefulness of AHIauto for the
assessment of titration reliability has not been
evaluated in this study. Such considerations
may not apply to other autoCPAP devices, usingdifferent softwares packages. SaO2, evaluated
simultaneously with CPAP levels, proved sufficient
to identify all cases of unacceptable correction of
respiratory disorders. The addition of other re-
spiratory signals did not provide further useful
information.
Four cases of imperfect titration were due to
insufficient sleep time spent supine. Posture signal
alone identified only one of these subjects, as the
remaining three remained awake for most of the
time they spent supine. In fact, for most subjects
supine posture is the most uncomfortable position
to sleep, so that longer time is spent awake when
supine than when lying on a side. Therefore, a
reliable identification of sleep time spent supine
requires also the recording of the signal for sleep
scoring, like in full polysomnography.
Finally, 3 subjects showed either a short TST or
absence of REM sleep. Only signals for sleep
scoring, that are included only in polysomnographic
monitorings, could identify such cases.
Patients who did not receive fully reliable CPAP
titration due to inadequate sleep or posture were
on average less sleepy than the other subjects;
however, among them one subject had a very high
Epworth score. Contrary to the cases of failure due
to incomplete respiratory disorder correction, in
these patients new titration studies, when per-
formed, always led to prescribe a CPAP level that
was very similar to the one that would have been
prescribed following just the analysis of pressure
levels delivered by the autoCPAP device. In fact,
not all patients require a higher pressure in REM
sleep,11,13 and in the supine posture;13 however, it
is unknown how to identify in advance which
patients change pressure requirements with sleep
state or posture, so a fully reliable CPAP titration
still requires REM sleep and some sleep in the
supine posture.
One limitation of this study is that partially
arbitrary criteria for definition of satisfactory
titration had to be adopted, since methods for
identification of optimal CPAP are not well stan-
dardised, and precise cut-offs are not available.
The criteria that were used took into account
present knowledge on the importance of sleep
ARTICLE IN PRESS
Signals for titration by auto CPAP devices 319characteristics, posture, and correction of respira-
tory disorders in CPAP titration.9–14
Another limitation of this study is that no manual
titration was performed to compare the 95th
centile pressure level provided by the autoCPAP
with manually determined optimal pressure. There-
fore, possible cases of overestimates of optimal
pressure by the autoCPAP could not be identified.
Besides, flow limitation episodes were not
assessed. The importance of the persistence of
few or minor disorders, like a small number of
obstructive apneas and hypopneas or flow limita-
tion episodes, during administration of high pres-
sure levels is dubious: it has been demonstrated
that such events during administration of the best
achievable pressure level in a titration night do not
impair the following clinical success of CPAP
treatment.33 Thus we considered only the few
cases indicative of unsuccessful titration due to
incomplete correction of respiratory disorders
when apneas or hypopneas occurred even at the
highest pressures delivered.
In conclusion, titration by autoCPAP, performed
without any simultaneous monitoring, did not
provide fully reliable information about pressure
level correcting respiratory disorders during sleep
in410% of OSAS patients naı¨ve to ventilatory
treatment. Recording of respiratory signals and of
posture improved recognition of acceptable titra-
tions, but did not totally prevent misinterpreta-
tions, due to sporadic occurrence of inadequate
sleep. Therefore, these results support the need of
polysomnography for a fully reliable CPAP titration,
even when it is performed by autoCPAP.18 This
procedure has very high costs that cannot be
sustained in every country. We speculate that
initial adaptation at home to CPAP application,
and subsequent recording of oximetry and posture
during autoCPAP application could limit the risk of
insufficient sleep during titration. Further research
is needed to prove this hypothesis or to identify
other simple and economic methods to reliably
start CPAP treatment.Acknowledgement
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